U.S. General Surgical Instruments Market: USD 13.22B

Market Outlook

By 2035, the U.S. General Surgical Instruments Market is expected to reach approximately USD 13.22 billion, expanding at a compound annual growth rate of 7.80% during 2026-2035. The market was valued at USD 6.24 billion in 2025, following historical expansion from USD 4.60 billion in 2021 to USD 5.78 billion in 2024. Values in this report are expressed in USD billions.

This market estimate covers reusable and single-use handheld surgical instruments, laparoscopic access and tissue-manipulation devices, electrosurgical and advanced-energy instruments, stapling and mechanical closure systems used in general surgery, selected powered soft-tissue instruments, and robotic-compatible instruments and consumables. The scope excludes standalone surgical robots, operating-room imaging systems, implants, sutures, wound-care products, anesthesia equipment, and instruments dedicated exclusively to orthopedics, ophthalmology, dentistry, neurosurgery, or cardiovascular intervention.

The U.S. general surgical instruments industry is supported by one of the world’s largest procedure infrastructures. Approximately 46.5 million surgical procedures and a larger number of invasive procedures are performed in the country each year. The operating environment includes about 6,100 hospitals, more than 907,000 staffed beds, over 35.6 million annual hospital admissions, and a rapidly expanding ambulatory surgery center network. In 2024, 6,436 Medicare-certified ambulatory surgery centers treated approximately 3.4 million fee-for-service Medicare beneficiaries, while Medicare program and beneficiary spending on ASC services reached about USD 7.5 billion. This broad care-delivery base creates recurring demand for instruments that cut, dissect, grasp, clamp, retract, seal, staple, access, suction, irrigate, and manipulate tissue.

Historical growth was shaped by the normalization of elective surgery after the pandemic, restoration of hospital capital budgets, migration of procedures into ambulatory settings, and higher use of minimally invasive and robotic-assisted techniques. The market increased from USD 4.60 billion in 2021 to USD 4.95 billion in 2022, USD 5.34 billion in 2023, USD 5.78 billion in 2024, and USD 6.24 billion in 2025. Growth was strongest in disposable laparoscopic instruments, vessel-sealing devices, powered stapling, trocar and access systems, smoke evacuation, reposable instrument platforms, and robotic-compatible tools.

The market is not expanding solely because more operations are being performed. Revenue growth is increasingly linked to a higher instrument value per procedure. A conventional open procedure may use a substantial reusable tray, while a laparoscopic or robotic procedure can add trocars, energy devices, stapler reloads, insufflation accessories, specimen retrieval systems, clip appliers, suction-irrigation devices, and specialized graspers. Hospitals therefore evaluate instrument portfolios through total episode economics, including operating-room time, turnover speed, sterile-processing labor, tray weight, instrument failure, surgeon preference, waste generation, and the financial consequences of complications or case delays.

Introduction

According to the U.S. General Surgical Instruments Market Report, general surgical instruments form the physical interface between the surgeon and the operative field. Although many individual devices are mature, the category remains strategically important because instruments affect precision, hemostasis, tissue trauma, procedural speed, staff ergonomics, and the reliability of the surgical workflow. The market includes basic reusable instruments with multiyear service lives as well as high-value single-use devices that generate revenue with every procedure.

Demand is closely tied to the scale and diversity of general surgery. Common procedures include cholecystectomy, appendectomy, inguinal and ventral hernia repair, colorectal resection, breast surgery, thyroid and parathyroid surgery, bariatric procedures, soft-tissue excision, wound debridement, anorectal surgery, trauma surgery, and emergency abdominal operations. Gallstones alone affect an estimated 10% to 15% of the U.S. population, or nearly 25 million people, and close to one million people are diagnosed annually. Approximately one-quarter of newly diagnosed patients ultimately require treatment, usually surgery. Cancer also sustains a large surgical case base: the United States recorded an estimated 2.04 million new cancer diagnoses in 2025, including more than 154,000 projected colon and rectal cancer cases.

The demographic and metabolic profile of the country creates a durable demand floor. By 2030, one in five Americans is projected to be of retirement age, increasing the prevalence of gallbladder disease, hernias, malignancy, diverticular disease, and other conditions that frequently require surgery. Adult obesity prevalence was 40.3% during August 2021-August 2023, with severe obesity affecting approximately 9.4% of adults. Obesity increases the complexity of abdominal surgery and contributes to demand for bariatric surgery, longer instruments, reinforced stapling, advanced energy, wound protection, retraction, and minimally invasive access products.

Hospital procurement behavior is changing the competitive structure. Large integrated delivery networks increasingly standardize instrument sets across multiple sites, negotiate enterprise contracts, consolidate suppliers, and use value-analysis committees to challenge product duplication. A vendor must often demonstrate not only clinical performance but also tray optimization, repair turnaround, sterile-processing compatibility, staff training, supply continuity, and credible savings per case. In ASCs, the economic test is even more direct. Facilities prefer compact inventories, reliable single-use products, simplified setup, predictable cost per case, and instruments that help surgeons complete more cases within fixed operating hours.

The forecast period will be defined by the interaction of three models: reusable instrumentation, single-use procedural devices, and digitally enabled surgical platforms. Reusable instruments will remain essential because of their durability and low cost per use when utilization is high. Single-use devices will gain share in complex designs where cleaning validation, functional degradation, or cross-contamination risk is difficult to manage. Robotic and data-enabled instruments will increase the value of the instrument ecosystem by embedding articulation, force sensing, energy delivery, usage tracking, and software-driven performance into the tool itself.

Key Market Drivers: What Is Fueling the U.S. General Surgical Instruments Market?

The first major driver is the scale of surgical activity across hospitals and outpatient facilities. The U.S. healthcare system supports tens of millions of surgical and invasive procedures annually, creating replacement demand for reusable instruments and recurring consumption of disposable devices. The hospital base alone includes more than 35.6 million admissions each year, while outpatient surgery continues to gain share. Medicare covers more than 3,700 surgical procedures in ASCs, and the number of Medicare-certified ASCs increased by 2.2% in 2024 to 6,436 facilities. Each new center creates demand for foundational instrument trays, laparoscopic sets, energy generators, hand instruments, sterilization-compatible accessories, and procedure-specific disposable products.

A second driver is the migration from open surgery to laparoscopic and robotic-assisted surgery. Minimally invasive procedures usually require smaller access ports, longer shafts, specialized graspers, articulating dissectors, clip appliers, vessel-sealing tools, insufflation accessories, staplers, and specimen retrieval systems. This increases instrument specialization and creates a recurring consumables stream. Robotic-assisted surgery adds another layer of demand for wristed instruments, proprietary accessories, drapes, cannulas, energy tools, and instrument exchange systems. The shift is strongest in cholecystectomy, colorectal surgery, hernia repair, bariatric surgery, foregut surgery, and selected endocrine procedures.

A third driver is the burden of obesity and related abdominal disease. More than two in five U.S. adults have obesity, and severe obesity affects nearly one in ten. These patients have higher rates of gallbladder disease, ventral and incisional hernia, colorectal disease, diabetes-related complications, and metabolic conditions that may require surgery. Obesity also increases technical complexity, which can favor longer shafts, stronger tissue manipulation, advanced energy, bariatric-length staplers, wound protectors, reinforced closure systems, and ergonomically designed instruments that reduce fatigue during longer cases.

A fourth driver is the cancer surgery pipeline. More than two million new cancers were expected to be diagnosed in the United States in 2025. Surgery remains central to the treatment of breast, colorectal, gastric, pancreatic, liver, thyroid, skin, and soft-tissue cancers. General surgeons and surgical oncologists require reliable dissection, retraction, vessel sealing, stapling, specimen retrieval, margin control, and lymphatic management. The instrument opportunity is particularly attractive where complex cancer surgery is shifting toward minimally invasive or robotic approaches without reducing the need for open conversion capability.

A fifth driver is the expansion of ASCs and hospital outpatient departments. ASCs offer more convenient scheduling, lower patient cost sharing, and focused staffing. More than 95% of ASCs are for-profit and approximately 94% are in urban areas, producing a procurement culture that emphasizes throughput and margin discipline. A product that saves several minutes of setup or reduces instrument exchanges may have greater economic value in an ASC than a small reduction in acquisition price. Manufacturers that can provide procedure packs, standardized preference cards, rapid replenishment, low-capital energy systems, and clinician training are positioned to capture this shift.

A sixth driver is hospital pressure to reduce sterile-processing complexity. Reprocessing reusable instruments is labor-intensive and requires point-of-use care, cleaning, inspection, assembly, packaging, sterilization, storage, and traceability. Surgical forceps, clamps, scissors, and similar devices are critical devices because they contact blood or sterile tissue and must be sterile at use. Heavy trays, damaged insulation, dull cutting surfaces, misaligned jaws, and missing instruments can delay cases and create patient-safety risk. This encourages tray rationalization, instrument tracking, modular sets, repair programs, and selective conversion to single-use products where total lifecycle economics are favorable.

A seventh driver is the need for supply-chain resilience. General surgical instruments include high-volume products sourced through global metalworking, polymer, electronics, packaging, and sterilization networks. Health systems are reducing dependence on a single factory or geography, holding higher safety stock for critical items, and requiring vendors to disclose back-order risk. Domestic manufacturing capability, dual sourcing, local repair, and distributor inventory depth increasingly influence purchasing decisions. The strategic value of reliable availability is greatest for stapler reloads, energy devices, trocars, clip systems, and proprietary robotic instruments that cannot be easily substituted during a case.

An eighth driver is reimbursement-linked procedure economics. Medicare and commercial payers generally reimburse the surgical episode rather than each instrument separately. Hospitals and ASCs therefore absorb the cost of most surgical instruments within facility payments. This makes procurement highly sensitive to whether a device reduces operating time, conversion to open surgery, blood loss, complications, readmissions, or length of stay. Manufacturers with credible health-economic evidence can defend premium pricing more effectively than vendors relying only on technical specifications.

Innovation in Focus: How Manufacturers Are Raising the Bar

Innovation in general surgical instruments is moving from isolated mechanical improvement toward integrated procedural performance. The competitive question is no longer simply whether an instrument cuts or grasps. Buyers increasingly ask whether it reduces exchanges, standardizes outcomes, supports difficult tissue, lowers hand fatigue, simplifies reprocessing, integrates with an energy platform, and produces data that can be used for training or quality improvement.

Advanced energy is one of the most important innovation areas. Bipolar vessel sealing, ultrasonic dissection, and hybrid energy platforms combine cutting, coagulation, sealing, and tissue manipulation. Modern devices use feedback algorithms to regulate energy delivery, monitor tissue impedance, and improve consistency. Multifunctionality can reduce the number of instruments opened for a case and decrease exchanges during laparoscopic procedures. The commercial advantage increasingly depends on the full system: generator footprint, compatibility across specialties, disposable instrument breadth, ergonomics, sealing speed, service support, and contracting flexibility.

Surgical stapling is undergoing a new technology cycle. Powered firing, tissue-thickness sensing, articulation, compression control, reload identification, and improved staple-line design are being used to address bleeding, leakage, and malformed staples. The U.S. launch of the ETHICON 4000 Stapler in 2025 and continued development of procedure-specific systems such as the Titan SGS platform illustrate the shift toward more controlled and anatomically tailored stapling. Future competition will center on staple-line integrity, ease of use, compatibility with robotic platforms, reload economics, and evidence showing reduced procedural variability.

Robotic-compatible instruments are another high-growth category. The FDA clearance of the fifth-generation da Vinci 5 system in 2024 reinforced demand for instruments that support wristed articulation, stable tissue handling, integrated energy, force feedback, and digital usage monitoring. As robotic surgery expands beyond large academic centers into community hospitals and selected ASCs, the addressable market for robotic instruments and accessories will increase. However, adoption will be constrained by per-procedure cost, proprietary ecosystems, training requirements, instrument life limits, and the need to demonstrate superiority over conventional laparoscopy.

Ergonomics is becoming a measurable purchasing criterion. Repetitive squeezing, awkward wrist posture, instrument torque, and long case duration contribute to surgeon fatigue and musculoskeletal strain. Manufacturers are redesigning handle geometry, activation controls, shaft rotation, grip span, weight distribution, and jaw mechanics. Ergonomic improvement is commercially meaningful when it enhances precision late in a case, reduces hand fatigue, or supports surgeons with different hand sizes. It can also improve staff acceptance during conversion from a familiar instrument platform.

Instrument traceability is advancing through laser marking, unique device identification, radio-frequency identification, barcode systems, and sterile-processing software. Hospitals want to know how many cycles an instrument has completed, when it was repaired, where it is located, whether it belongs in the tray, and whether its inspection is overdue. Data-enabled inventory management can reduce lost instruments, emergency purchases, overbuilt trays, and case delays. Over time, traceability data may also support predictive maintenance and outcome analysis.

Materials innovation is improving instrument life and performance. High-grade stainless steels remain dominant, but manufacturers are using titanium, tungsten-carbide inserts, advanced polymers, ceramic coatings, insulation systems, and low-friction surface treatments to improve cutting, reduce weight, resist corrosion, and support repeated sterilization. Single-use instruments are also becoming more sophisticated as polymer molding, miniaturized electronics, and compact energy components allow complex functions to be delivered in disposable form.

Sustainability is creating a more nuanced innovation agenda. Hospitals are under pressure to reduce regulated medical waste and greenhouse-gas emissions, but they must also account for water, chemicals, steam, packaging, transportation, repair, and labor associated with reusable instruments. The most credible sustainability strategies use lifecycle analysis rather than assuming that reusable or disposable is always superior. Vendors that offer reprocessing programs, recyclable packaging, reduced material use, instrument repair, and transparent environmental data can strengthen their position in enterprise tenders.

Segmentation Insights

The U.S. General Surgical Instruments Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Handheld surgical instruments represent the largest and most stable product category. The segment includes forceps, clamps, scissors, needle holders, retractors, dissectors, probes, hooks, curettes, rongeurs, suction instruments, and auxiliary tools. Reusable stainless-steel instruments dominate routine open surgery and remain essential as backup during minimally invasive cases. Revenue growth is supported by replacement of worn or lost instruments, expansion of surgical facilities, tray standardization, premium ergonomic designs, and repair services. The category is price competitive, but brands with consistent metallurgy, jaw alignment, cutting quality, and service support can retain strong hospital loyalty.
Laparoscopic access and tissue-manipulation instruments are a higher-growth category. Products include trocars, cannulas, Veress needles, graspers, dissectors, scissors, clip appliers, suction-irrigation devices, specimen retrieval systems, wound protectors, and port-closure instruments. Demand is driven by laparoscopic cholecystectomy, appendectomy, hernia repair, colorectal surgery, bariatric surgery, and foregut procedures. Single-use products have a strong position because of predictable sharpness, insulation integrity, and workflow simplicity, while reusable and reposable platforms remain attractive for high-volume systems seeking lower waste and long-term cost control.
Electrosurgical and advanced-energy instruments form one of the fastest-growing product categories. The segment includes monopolar pencils and electrodes, bipolar forceps, vessel-sealing devices, ultrasonic shears, hybrid energy instruments, smoke-management accessories, and compatible handpieces. These products command higher average selling prices because they combine dissection and hemostasis and can reduce instrument exchanges. Growth is strongest in devices that seal vessels up to 7 millimeters, offer precise thermal control, work across open and laparoscopic procedures, and connect to consolidated energy platforms.
Surgical stapling and mechanical closure instruments generate substantial recurring revenue through staplers, reloads, clip systems, ligation devices, skin staplers, and specialized closure tools. The segment is concentrated among large medtech companies because development requires engineering, clinical evidence, manufacturing precision, and extensive surgeon training. Growth is supported by colorectal, bariatric, thoracic, and upper gastrointestinal procedures. Hospitals increasingly scrutinize reload utilization, misfire risk, staple-line bleeding, tissue-thickness selection, and the total cost of managing leaks or reoperations.
Powered and robotic-compatible instruments are the highest-value emerging category. The segment includes powered soft-tissue dissection tools, powered staplers, robotic graspers, scissors, needle drivers, energy instruments, cannulas, and platform-specific accessories. The revenue model combines capital-linked adoption with recurring per-procedure consumption. Growth will be strongest where robotic surgery expands in colorectal, hernia, bariatric, and complex abdominal procedures. Competitive barriers include intellectual property, platform compatibility, surgeon training, and the ability to integrate instrument data with the broader robotic ecosystem.

By Application

Abdominal and gastrointestinal surgery is the largest application segment. It includes cholecystectomy, appendectomy, gastric surgery, small-bowel procedures, emergency laparotomy, hepatobiliary surgery, and selected pancreatic procedures. Gallstones affect nearly 25 million Americans, supporting a large recurring cholecystectomy base. These procedures use a broad mix of access devices, graspers, dissectors, clip appliers, energy instruments, suction-irrigation systems, staplers, retractors, and open surgical trays. The segment benefits from high procedure frequency and continued migration toward minimally invasive techniques.
Hernia repair is a strategically important application because it spans open, laparoscopic, and robotic approaches. Inguinal, ventral, incisional, and paraesophageal hernias require dissection, fixation, mesh positioning, closure, and tissue handling. Instrument demand is expanding as robotic repair gains adoption for complex ventral and recurrent hernias. Hospitals evaluate instruments alongside mesh, fixation, operating time, and recurrence risk. Vendors that support complete procedural workflows can achieve stronger contracting leverage than suppliers offering stand-alone instruments.
Colorectal surgery is a premium-value application driven by cancer, diverticular disease, inflammatory bowel disease, obstruction, and other conditions. The United States expected more than 154,000 new colon and rectal cancer cases in 2025. Colorectal procedures require advanced stapling, energy, access, specimen extraction, retraction, anastomotic assessment, and open conversion instruments. Robotic and laparoscopic approaches are increasing, but the need for reliable open instruments remains. Growth is strongly linked to evidence on leak reduction, perfusion assessment, tissue compression, and standardized anastomosis.
Bariatric and metabolic surgery uses high-value staplers, reloads, energy devices, liver retractors, long-shaft instruments, trocars, specimen systems, and closure products. The addressable clinical population is large because 40.3% of U.S. adults have obesity and 9.4% have severe obesity. Procedure volumes are influenced by insurance coverage, patient preference, and the expanding use of anti-obesity medicines. Even if pharmacotherapy moderates growth in some bariatric procedures, severe obesity and metabolic disease will preserve a substantial surgical market, particularly for patients requiring durable weight loss or treatment of complex comorbidities.
Breast, endocrine, soft-tissue, and trauma surgery provide a diverse demand base. Breast cancer surgery requires fine dissection, retractors, electrosurgery, specimen orientation, and lymphatic instruments. Thyroid and parathyroid procedures favor precise energy, nerve-protection workflows, and delicate instrumentation. Trauma and emergency surgery require robust, immediately available open trays, suction, vascular clamps, retractors, and rapid hemostatic tools. These applications are less standardized than high-volume elective procedures, creating opportunities for broad portfolio vendors and specialty instrument manufacturers.

By End User

Hospitals and integrated health systems are the dominant end users. They perform the majority of complex abdominal, cancer, emergency, and high-risk surgery and purchase both reusable instrument fleets and high-value disposable devices. Large systems use enterprise contracts, group purchasing organizations, and value-analysis committees to standardize suppliers. Their decisions are influenced by clinical preference, supply assurance, service coverage, sterile-processing performance, cybersecurity for connected platforms, and the ability to support multiple specialties. Hospitals increasingly favor vendors that can consolidate product categories and provide utilization analytics.
Ambulatory surgery centers are the fastest-growing end-user segment for appropriate general surgical procedures. The United States had 6,436 Medicare-certified ASCs in 2024, up from 5,760 in 2019. ASCs emphasize low capital intensity, efficient room turnover, predictable supply cost, and minimal reprocessing burden. They are attractive for laparoscopic cholecystectomy, hernia repair, selected breast procedures, anorectal surgery, and other lower-acuity cases. Single-use and procedure-specific products often perform well in this setting because they reduce tray assembly, repair management, and sterilization complexity.
Academic medical centers and major teaching hospitals are strategically important because they adopt complex technology, participate in clinical trials, train surgeons, and influence national practice patterns. These institutions are early evaluators of robotic systems, advanced energy, digital surgery, next-generation stapling, and complex minimally invasive techniques. Procurement is evidence intensive and may involve multidisciplinary committees. Commercial success in a leading academic center can create training visibility and facilitate adoption across affiliated community hospitals.
Specialty surgical hospitals and physician-led centers are important buyers in markets such as bariatric, colorectal, hernia, breast, and minimally invasive surgery. These facilities often have high procedure concentration and strong surgeon influence over purchasing. They may adopt premium instruments when the product improves throughput, reduces variability, or supports a differentiated surgical program. Manufacturers must provide responsive clinical education and reliable inventory because a narrow procedure mix can magnify the impact of supply disruption.
Federal, military, Veterans Health Administration, and safety-net facilities represent a smaller but strategically relevant end-user group. Procurement is influenced by public tendering, standardized contracts, domestic sourcing considerations, and the need to support geographically distributed facilities. These buyers value durable reusable instruments, long service life, repairability, and supply continuity. They also require broad clinical coverage because many facilities operate with constrained specialty access and must maintain readiness for emergency and general surgical care.

By Technology Type

Conventional reusable instruments remain the largest technology type by installed base. Their economic advantage is strongest in high-volume hospitals with mature sterile-processing operations. A well-maintained instrument can be used for many years, producing a low cost per case. The main challenges are inspection labor, repair, tray weight, corrosion, loss, and inconsistent performance after repeated use. Growth will come from premium materials, modular trays, instrument tracking, ergonomic handles, and service agreements rather than from simple unit expansion.
Single-use and disposable instruments are growing faster than conventional reusable products. They offer consistent sharpness, insulation, sterility, and predictable functionality. Adoption is strongest for trocars, vessel sealers, ultrasonic instruments, staplers, reloads, clip appliers, retrieval systems, and complex laparoscopic tools. The trade-off is higher per-case cost and greater waste. Manufacturers that reduce packaging, use lower-mass materials, and provide credible sustainability data can improve acceptance among environmentally focused health systems.
Reposable and hybrid instruments combine a reusable handle or shaft with disposable tips, blades, cartridges, or patient-contact components. This model seeks to balance performance consistency with lower waste and lifecycle cost. It is attractive where the most failure-prone or contamination-sensitive component can be replaced while the durable portion is reused. Commercial success depends on easy assembly, transparent reprocessing instructions, dependable component supply, and economics that are clearly better than fully reusable or fully disposable alternatives.
Energy-enabled and powered instruments are expanding because they can improve hemostasis and procedural efficiency. The category includes advanced bipolar, ultrasonic, hybrid, powered stapling, and selected powered dissection systems. Growth is supported by multifunctionality and integration with consolidated generators. Buyers evaluate vessel-sealing reliability, thermal spread, speed, ergonomics, generator utilization, and disposable pricing. Vendor lock-in can be substantial because instrument choice is often tied to a generator platform and enterprise contract.
Robotic, sensor-enabled, and digitally tracked instruments are expected to record the fastest growth through 2035. These tools may incorporate articulation, force feedback, energy control, usage limits, automatic recognition, and software-linked performance data. They can support training, workflow analysis, and predictive maintenance. Their economic challenge is proving that higher instrument cost translates into better outcomes, shorter procedures, or broader patient eligibility. As digital surgery matures, instrument data will become a strategic asset rather than a by-product.

Regional Insights: Where the Market Is Growing Fastest

The U.S. General Surgical Instruments Market is geographically segmented into the South, Northeast, West, and Midwest. Regional performance varies according to population, age profile, obesity burden, hospital and ASC density, academic medical center concentration, surgeon availability, payer mix, certificate-of-need rules, and adoption of minimally invasive and robotic surgery. The South represented the largest market in 2025, while the West is expected to grow fastest through 2035.

South

The South accounted for an estimated USD 2.15 billion in 2025 and is projected to reach approximately USD 4.55 billion by 2035. The region includes Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. Its market leadership is supported by population scale, rapid metropolitan growth, high obesity prevalence, large Medicare populations, expanding health systems, and substantial demand for gallbladder, hernia, colorectal, bariatric, breast, and emergency surgery.

Texas and Florida are the two largest state markets in the region. Texas combines a large population with major surgical hubs in Houston, Dallas-Fort Worth, Austin, and San Antonio. The state has broad hospital and ASC infrastructure and strong demand for minimally invasive, bariatric, colorectal, and trauma instruments. Florida’s older population supports high volumes of cancer, hernia, gallbladder, and colorectal procedures. Both states are priority markets for vendors seeking enterprise health-system contracts and ASC penetration.

Georgia, North Carolina, Tennessee, Virginia, and Maryland are high-growth markets because of population migration, academic centers, expanding suburban hospital networks, and significant ASC activity. Georgia is among the states with a high concentration of ASCs per Medicare beneficiary. North Carolina’s easing of certificate-of-need restrictions for certain ASC development can support additional outpatient capacity. Maryland has an unusually high ASC concentration and a payment environment that encourages care migration from hospital outpatient departments to lower-cost settings.

Alabama, Arkansas, Kentucky, Louisiana, Mississippi, Oklahoma, South Carolina, and West Virginia have smaller absolute markets but elevated obesity and chronic disease burdens. Mississippi and West Virginia reported adult obesity prevalence of at least 40% in 2024, while the South overall had one of the country’s highest regional obesity rates. These states generate strong need for abdominal, hernia, wound, and emergency surgical instruments, although rural access, workforce shortages, and limited robotic infrastructure can slow premium technology adoption outside major referral centers.

Northeast

The Northeast represented an estimated USD 1.47 billion in 2025 and is projected to reach approximately USD 3.00 billion by 2035. The region includes Connecticut, Delaware, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. It has a high concentration of academic medical centers, teaching hospitals, cancer centers, and sophisticated integrated delivery networks. The region is mature in conventional instrumentation but remains attractive for premium energy, stapling, robotic, and traceability technologies.

New York is the largest state market in the Northeast, supported by population density, large hospital systems, and high surgical complexity. Pennsylvania and New Jersey provide substantial community hospital and ambulatory procedure volumes, with strong demand for colorectal, bariatric, breast, and hernia instruments. Massachusetts has an outsized influence on innovation because of its academic institutions, surgical research programs, and early adoption of advanced technology. Procurement in these states is rigorous, and vendors must demonstrate clinical evidence, supply reliability, and enterprise economic value.

Connecticut, Delaware, Rhode Island, New Hampshire, Maine, and Vermont are smaller markets with different strategic profiles. Connecticut and Delaware benefit from proximity to dense regional referral networks and major metropolitan markets. New Hampshire, Maine, and Vermont have older and more rural populations, favoring durable reusable instruments, regional service support, and solutions that can be deployed in smaller hospitals. Vermont has one of the lowest ASC concentrations per Medicare beneficiary, which keeps a larger share of general surgical demand within hospital settings.

The Northeast is expected to grow slightly below the national rate because of slower population growth and high existing technology penetration. Nevertheless, revenue per procedure is high because of complex case mix, premium product adoption, and concentration of surgical oncology and academic programs. The region is particularly valuable for clinical validation, surgeon advocacy, and launches of advanced energy, robotic-compatible, and data-enabled instruments.

West

The West accounted for an estimated USD 1.44 billion in 2025 and is forecast to reach approximately USD 3.31 billion by 2035, making it the fastest-growing region. The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. Growth is driven by population expansion in the Mountain states, technology adoption on the West Coast, strong medtech and digital-health ecosystems, and increasing use of robotic and ambulatory surgery.

California is the largest state market in the West. Its scale, academic medical centers, integrated health systems, and innovation culture support early adoption of robotic platforms, advanced energy, digital instrument tracking, and sustainability-focused procurement. California’s large ambulatory market also favors standardized disposable and reposable instruments. Washington and Oregon have sophisticated health systems with strong interest in workflow integration, environmental performance, and system-wide contracting.

Arizona, Nevada, Colorado, and Utah are high-growth markets. Arizona and Nevada combine rapid population growth with expanding older populations and strong ASC development. Arizona had one of the higher ASC concentrations per Medicare beneficiary in 2024. Colorado and Utah have growing metropolitan surgical capacity, integrated provider systems, and strong adoption of minimally invasive techniques. These states are attractive for robotic general surgery, outpatient hernia repair, bariatric procedures, and advanced stapling.

Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii are smaller but strategically distinct. Idaho is growing rapidly and adding surgical capacity. Montana and Wyoming require regional distribution and service models that can cover wide geographies. New Mexico has relatively low ASC concentration despite lacking a stringent ASC certificate-of-need structure, reflecting rural population dispersion. Alaska has a high ASC concentration relative to its Medicare population, while Hawaii’s island geography makes inventory reliability and supply continuity especially important.

Midwest

The Midwest represented an estimated USD 1.18 billion in 2025 and is projected to reach approximately USD 2.36 billion by 2035. The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. It provides a stable base of hospital surgery, mature community health systems, strong general surgery networks, and significant chronic disease burden. Growth is steady rather than speculative, with emphasis on value, durability, and service.

Illinois, Ohio, Michigan, and Minnesota are the largest state markets. Illinois benefits from Chicago’s academic and community hospital ecosystem. Ohio has major integrated systems and a broad surgical referral base. Michigan supports significant abdominal, cancer, bariatric, and emergency surgery demand. Minnesota is strategically important because of its medical technology ecosystem, clinical research capabilities, and concentration of sophisticated health systems.

Indiana, Wisconsin, Missouri, Iowa, Kansas, and Nebraska provide durable demand for reusable instruments, laparoscopic products, energy devices, and stapling systems. The Midwest had the highest regional adult obesity prevalence in 2024 at approximately 35.9%, supporting ongoing need for hernia, gallbladder, colorectal, and metabolic surgery. Many systems in these states are highly cost conscious and favor vendors that can demonstrate tray savings, repair efficiency, standardization, and reliable distribution.

North Dakota and South Dakota are smaller markets with dispersed populations and regional referral patterns. Their opportunity is concentrated in larger urban centers and health systems that serve wide geographic catchments. Remote locations increase the value of instrument durability, local inventory, and rapid repair turnaround. The Midwest is expected to remain an important market for companies that compete on clinical consistency, operational support, and total cost of ownership rather than premium technology alone.

Key Market Players

The U.S. General Surgical Instruments Competitive Landscape is moderately consolidated in advanced energy, stapling, laparoscopic access, and robotic-compatible instruments, while reusable handheld instruments remain fragmented. Large medtech companies compete through broad procedural platforms, enterprise contracting, surgeon training, clinical evidence, and national distribution. Specialized manufacturers compete through craftsmanship, niche designs, repair services, custom trays, and rapid product development.

Some of the key players in the U.S. General Surgical Instruments industry are:

Johnson & Johnson MedTech (Ethicon)
Medtronic
Stryker
B. Braun Medical / Aesculap
BD
Olympus Corporation of the Americas
CONMED Corporation
Integra LifeSciences
Teleflex Incorporated
Applied Medical Resources
KARL STORZ
Richard Wolf
Intuitive Surgical
CooperSurgical
Smith+Nephew
Cardinal Health
Medline Industries
STERIS
Aspen Surgical
Sklar Surgical Instruments
KLS Martin
Scanlan International
Microline Surgical
Cook Medical
Wexler Surgical

Johnson & Johnson MedTech and Medtronic have leading positions in surgical stapling, advanced energy, and broad general surgery portfolios. Olympus and CONMED compete strongly in energy, laparoscopy, insufflation, smoke management, and operating-room platforms. B. Braun/Aesculap, BD, Integra, Sklar, KLS Martin, Scanlan, and Wexler are important in reusable instrumentation and specialty hand instruments. Applied Medical has a strong position in minimally invasive access and cost-focused procedural devices. Teleflex participates through ligation, bariatric stapling, access, and surgical products. Intuitive Surgical influences the fastest-growing robotic-compatible instrument segment through a proprietary recurring-revenue ecosystem.

Market share through 2035 will be determined by the ability to secure enterprise contracts, protect surgeon preference, provide reliable supply, manage sterilization and repair requirements, and generate clinical and economic evidence. Companies that combine instruments, capital platforms, digital data, training, and service will have greater pricing power. Smaller manufacturers can remain competitive by solving specific ergonomic, reprocessing, or procedural problems that broad portfolio companies do not address effectively.

Recent Developments

In March 2024, Intuitive Surgical received FDA clearance for the da Vinci 5 multiport robotic system. The clearance marked a new robotic technology cycle and reinforced demand for platform-compatible instruments, accessories, and recurring consumables. For the general surgical instruments market, the strategic significance is the continued movement of instrument value from conventional mechanical tools toward articulated, sensor-enabled, digitally monitored devices.

In 2024, Olympus expanded the commercial availability of its ESG-410 surgical energy platform, designed to support monopolar, bipolar, advanced bipolar, ultrasonic, and hybrid energy from a consolidated generator. The company also launched additional POWERSEAL 5-millimeter sealer/divider jaw designs in August 2024. In April 2026, Olympus announced FDA clearance for a POWERSEAL Open Extended Jaw device, extending the platform into open surgery. These developments illustrate the competitive shift toward broad energy ecosystems that can serve multiple specialties and surgical approaches.

In June 2025, Johnson & Johnson MedTech launched the ETHICON 4000 Stapler in the United States with new reload and gripping technologies designed to manage tissue complexity and strengthen staple-line performance. The launch reflects ongoing investment in powered and controlled stapling, an area where hospitals are willing to evaluate premium pricing when the technology can reduce leaks, bleeding, and procedural variability.

Teleflex expanded its Titan SGS bariatric stapling platform in 2024 by offering a staple-line reinforcement option. The company reported that more than 10,000 U.S. sleeve gastrectomy procedures had been completed with the system since its market introduction. This is an example of procedure-specific instrument design, where a manufacturer seeks to improve standardization by building a stapler around the anatomy and workflow of a defined operation.

The regulatory environment also changed. The FDA issued final guidance in May 2024 clarifying the distinction between device servicing and remanufacturing, an important issue for reusable and repairable medical devices. On February 2, 2026, the FDA’s Quality Management System Regulation became effective, incorporating ISO 13485:2016 into the U.S. device quality framework and introducing a new inspection process. Instrument manufacturers must now place greater emphasis on risk management, supplier controls, lifecycle documentation, complaint handling, and quality-system consistency.

The outpatient market continued to expand. Medicare-certified ASCs increased from 5,760 in 2019 to 6,436 in 2024, with 248 new centers opening and 108 closing or merging during 2024. ASC procedure volume per fee-for-service beneficiary grew 3.5% in 2024. This expansion is strategically important because ASCs often prefer standardized, efficient, lower-capital instrument portfolios and can accelerate adoption of single-use, reposable, and compact energy systems.

Conclusion

The U.S. General Surgical Instruments Market Size & Share is positioned to expand from USD 6.24 billion in 2025 to approximately USD 13.22 billion by 2035, representing a CAGR of 7.80% during 2026-2035. The market’s durability is grounded in tens of millions of annual surgical and invasive procedures, more than 6,000 hospitals, a growing network of over 6,400 Medicare-certified ASCs, an aging population, high obesity prevalence, and sustained demand for abdominal, hernia, colorectal, cancer, bariatric, trauma, and emergency surgery.

The highest-growth opportunities will come from advanced energy, powered stapling, laparoscopic access, robotic-compatible instruments, traceability, ergonomic design, and hybrid reusable-disposable platforms. Conventional handheld instruments will remain essential, but growth will depend more on premium quality, tray optimization, repair services, and data-enabled lifecycle management than on basic unit volume. Hospitals will continue to use reusable instruments where utilization supports favorable cost per use, while converting selected complex or difficult-to-reprocess devices to single-use formats.

Regional opportunity will be led by the South because of population scale, obesity burden, metropolitan expansion, and high surgical demand. The West will grow fastest as robotic, digital, and ambulatory surgery expands. The Northeast will remain influential for complex care, evidence generation, and premium technology adoption. The Midwest will provide stable, cost-conscious demand supported by mature health systems and a high chronic disease burden.

For manufacturers, investors, distributors, and healthcare providers, the central market question is not whether surgical instrument demand will increase. The more important questions are which instruments will become embedded in standardized procedural pathways, which technologies can prove economic value under bundled facility reimbursement, and which suppliers can provide dependable national service and supply. Companies that combine instrument performance with workflow efficiency, sterile-processing support, clinical evidence, digital traceability, and resilient manufacturing will define the next decade of the U.S. general surgical instruments industry.

TABLE OF CONTENT

1. U.S. General Surgical Instruments Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Analytical Frameworks & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. General Surgical Instrument Manufacturers
1.6.2. Raw Material, Component and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Ambulatory Surgery Centers and Physician-Led Surgical Facilities
1.6.5. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.6. Sterile Processing, Instrument Repair and Lifecycle Service Providers
1.6.7. Surgeons, Regulators, Payers and Clinical Decision-Makers

What this section provides: This section defines the market boundary, research scope, methodology, assumptions, product inclusion criteria and stakeholder ecosystem used to measure and validate the U.S. general surgical instruments market.

2. U.S. General Surgical Instruments Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Product and Procedure Areas
2.9. Major Investment and Commercial Priorities

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, major demand pockets, competitive intensity and priority commercial opportunities.

3. U.S. General Surgical Instruments Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Volume of General Surgical Procedures
3.1.2. Migration from Open Surgery to Laparoscopic and Robotic-Assisted Surgery
3.1.3. Expansion of Ambulatory Surgery Centers and Outpatient Procedures
3.1.4. Growing Burden of Obesity, Gallbladder Disease, Hernias and Gastrointestinal Disorders
3.1.5. Rising Cancer-Related Surgical Intervention
3.1.6. Demand for Advanced Energy, Stapling and Tissue-Sealing Instruments
3.1.7. Hospital Tray Standardization and Sterile-Processing Optimization
3.1.8. Replacement Demand for Reusable Surgical Instruments
3.2. Restraints and Their Impact Analysis
3.2.1. Pricing Pressure from Hospitals, IDNs and Group Purchasing Organizations
3.2.2. High Per-Procedure Cost of Advanced Disposable Instruments
3.2.3. Reprocessing Complexity and Sterile-Processing Workforce Constraints
3.2.4. Product Recalls, Instrument Failure and Patient-Safety Risks
3.2.5. Environmental Concerns Associated with Single-Use Surgical Products
3.2.6. Surgeon Preference and Vendor-Switching Resistance
3.3. Opportunities and Their Impact Analysis
3.3.1. Advanced Bipolar, Ultrasonic and Hybrid Energy Instruments
3.3.2. Powered and Intelligent Surgical Stapling Systems
3.3.3. Robotic-Compatible and Articulating Surgical Instruments
3.3.4. Single-Use and Reposable Instrument Platforms
3.3.5. Instrument Tracking, UDI and Predictive Maintenance Solutions
3.3.6. Procedure-Specific Instrument Kits for Ambulatory Surgery Centers
3.3.7. Sustainable Materials, Repair Services and Circular Instrument Models
3.4. Challenges and Their Impact Analysis
3.4.1. Supply-Chain Concentration and Raw Material Volatility
3.4.2. Maintaining Instrument Quality Across Repeated Sterilization Cycles
3.4.3. Demonstrating Clinical and Economic Value to Procurement Committees
3.4.4. Balancing Standardization with Surgeon-Specific Preferences
3.4.5. Managing Proprietary Instrument and Capital Platform Compatibility
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Surgical Workflow Economics Analysis
3.7. Hospital Capital and Consumable Procurement Behavior Analysis
3.8. Reusable Versus Disposable Lifecycle Cost Analysis
3.9. Sterile-Processing Department Impact Analysis

What this section provides: This section explains the clinical, commercial, reimbursement, operational and procurement forces shaping demand, helping clients evaluate market opportunities, adoption barriers and execution risks.

4. U.S. General Surgical Instruments Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political Factors
4.1.2. Economic Factors
4.1.3. Social Factors
4.1.4. Technological Factors
4.1.5. Environmental Factors
4.1.6. Legal Factors
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Product and Technology Substitution
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Stainless Steel, Titanium, Polymer and Specialty Material Analysis
4.6. Application & Innovation Landscape
4.7. Digital Instrument Tracking and Operating-Room Connectivity
4.8. FDA Medical Device Regulatory Framework Analysis
4.9. FDA Quality Management System Regulation Impact
4.10. CMS Reimbursement and Procedure Payment Landscape
4.11. Unique Device Identification and Traceability Requirements
4.12. Import, Export, Tariff and Domestic Sourcing Analysis
4.13. Government Procurement and Public Health System Demand
4.14. Impact of Escalating Geopolitical and Trade Tensions
4.15. Sustainability and Medical Waste Management Analysis
4.16. Hospital Value Analysis Committee Decision Framework

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, raw materials, supply chains, sustainability, technology adoption and hospital procurement dynamics.

5. U.S. General Surgical Instruments Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Handheld Surgical Instruments
5.1.2.1. Forceps and Graspers
5.1.2.2. Surgical Scissors
5.1.2.3. Clamps and Occluding Instruments
5.1.2.4. Needle Holders
5.1.2.5. Retractors
5.1.2.6. Dissectors, Probes and Hooks
5.1.2.7. Suction, Irrigation and Auxiliary Hand Instruments
5.1.3. Laparoscopic Access and Tissue-Manipulation Instruments
5.1.3.1. Trocars and Cannulas
5.1.3.2. Veress Needles and Access Needles
5.1.3.3. Laparoscopic Graspers and Dissectors
5.1.3.4. Laparoscopic Scissors
5.1.3.5. Clip Appliers
5.1.3.6. Suction-Irrigation Instruments
5.1.3.7. Specimen Retrieval Systems
5.1.3.8. Wound Protectors and Port-Closure Instruments
5.1.4. Electrosurgical and Advanced-Energy Instruments
5.1.4.1. Monopolar Instruments
5.1.4.2. Conventional Bipolar Instruments
5.1.4.3. Advanced Bipolar Vessel-Sealing Instruments
5.1.4.4. Ultrasonic Surgical Instruments
5.1.4.5. Hybrid Energy Instruments
5.1.4.6. Smoke-Evacuation-Enabled Instruments
5.1.5. Surgical Stapling and Mechanical Closure Instruments
5.1.5.1. Manual Surgical Staplers
5.1.5.2. Powered Surgical Staplers
5.1.5.3. Linear Cutters and Reloads
5.1.5.4. Circular Staplers
5.1.5.5. Skin Staplers
5.1.5.6. Clips and Ligation Systems
5.1.5.7. Specialized Mechanical Closure Instruments
5.1.6. Powered and Robotic-Compatible Instruments
5.1.6.1. Powered Soft-Tissue Dissection Instruments
5.1.6.2. Powered Stapling Instruments
5.1.6.3. Robotic Graspers and Forceps
5.1.6.4. Robotic Scissors and Dissectors
5.1.6.5. Robotic Needle Drivers
5.1.6.6. Robotic Energy Instruments
5.1.6.7. Robotic Cannulas and Platform-Specific Accessories

What this section provides: This section identifies the product categories and subcategories expected to generate the highest revenue contribution, recurring procedural demand and strongest growth through 2035.

6. U.S. General Surgical Instruments Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Abdominal and Gastrointestinal Surgery
6.1.2.1. Cholecystectomy
6.1.2.2. Appendectomy
6.1.2.3. Gastric and Small-Bowel Surgery
6.1.2.4. Hepatobiliary Surgery
6.1.2.5. Pancreatic Surgery
6.1.2.6. Emergency Laparotomy
6.1.3. Hernia Repair
6.1.3.1. Inguinal Hernia Repair
6.1.3.2. Ventral Hernia Repair
6.1.3.3. Incisional Hernia Repair
6.1.3.4. Paraesophageal and Hiatal Hernia Repair
6.1.3.5. Recurrent and Complex Abdominal Wall Reconstruction
6.1.4. Colorectal Surgery
6.1.4.1. Colon Cancer Surgery
6.1.4.2. Rectal Cancer Surgery
6.1.4.3. Diverticular Disease Surgery
6.1.4.4. Inflammatory Bowel Disease Surgery
6.1.4.5. Bowel Obstruction and Emergency Colorectal Surgery
6.1.4.6. Anorectal Procedures
6.1.5. Bariatric and Metabolic Surgery
6.1.5.1. Sleeve Gastrectomy
6.1.5.2. Gastric Bypass
6.1.5.3. Revisional Bariatric Surgery
6.1.5.4. Other Metabolic Surgical Procedures
6.1.6. Breast, Endocrine, Soft-Tissue and Trauma Surgery
6.1.6.1. Breast-Conserving and Mastectomy Procedures
6.1.6.2. Thyroid and Parathyroid Surgery
6.1.6.3. Soft-Tissue Excision and Reconstruction
6.1.6.4. Wound Debridement
6.1.6.5. Trauma and Emergency General Surgery

What this section provides: This section helps clients understand instrument demand by surgical use case and prioritize applications with strong procedure volumes, reimbursement relevance, recurring consumable use and technology adoption.

7. U.S. General Surgical Instruments Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Large Integrated Delivery Networks
7.1.2.2. Community Hospitals
7.1.2.3. Regional Referral Hospitals
7.1.2.4. Rural and Critical Access Hospitals
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Independent Ambulatory Surgery Centers
7.1.3.2. Hospital-Affiliated Ambulatory Surgery Centers
7.1.3.3. Physician-Owned Ambulatory Surgery Centers
7.1.3.4. Corporate Multi-Site ASC Networks
7.1.4. Academic Medical Centers and Teaching Hospitals
7.1.4.1. University-Affiliated Medical Centers
7.1.4.2. Surgical Training and Research Institutions
7.1.4.3. Comprehensive Cancer Centers
7.1.5. Specialty Surgical Hospitals and Physician-Led Centers
7.1.5.1. Bariatric Surgery Centers
7.1.5.2. Colorectal and Gastrointestinal Surgery Centers
7.1.5.3. Hernia and Abdominal Wall Centers
7.1.5.4. Breast and Endocrine Surgery Centers
7.1.6. Federal, Military, Veterans Health and Safety-Net Facilities
7.1.6.1. Veterans Health Administration Facilities
7.1.6.2. Department of Defense and Military Treatment Facilities
7.1.6.3. Federal and Public Hospitals
7.1.6.4. Safety-Net and County Health Systems

What this section provides: This section explains which care settings and customer groups are expected to drive instrument purchasing, reusable fleet replacement, disposable utilization and adoption of advanced surgical technologies.

8. U.S. General Surgical Instruments Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Reusable Instruments
8.1.2.1. Stainless-Steel Instruments
8.1.2.2. Titanium Instruments
8.1.2.3. Tungsten-Carbide-Enhanced Instruments
8.1.2.4. Coated and Insulated Instruments
8.1.3. Single-Use and Disposable Instruments
8.1.3.1. Disposable Handheld Instruments
8.1.3.2. Disposable Laparoscopic Instruments
8.1.3.3. Disposable Energy Instruments
8.1.3.4. Disposable Staplers and Reloads
8.1.3.5. Disposable Access and Retrieval Products
8.1.4. Reposable and Hybrid Instruments
8.1.4.1. Reusable Handles with Disposable Tips
8.1.4.2. Reusable Shafts with Disposable Patient-Contact Components
8.1.4.3. Modular and Interchangeable Instrument Systems
8.1.5. Energy-Enabled and Powered Instruments
8.1.5.1. Advanced Bipolar Systems
8.1.5.2. Ultrasonic Systems
8.1.5.3. Hybrid Energy Systems
8.1.5.4. Powered Stapling Systems
8.1.5.5. Powered Dissection Systems
8.1.6. Robotic, Sensor-Enabled and Digitally Tracked Instruments
8.1.6.1. Articulating Robotic Instruments
8.1.6.2. Force-Feedback and Haptic Instruments
8.1.6.3. Sensor-Enabled Tissue-Assessment Instruments
8.1.6.4. UDI, RFID and Barcode-Tracked Instruments
8.1.6.5. Software-Linked Instrument Utilization Platforms

What this section provides: This section evaluates reusable, disposable, reposable, powered, robotic and digitally connected technologies shaping surgical performance, lifecycle economics and purchasing decisions.

9. U.S. General Surgical Instruments Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Department-Level Purchasing
9.1.2.2. Hospital Value Analysis Committee Approval
9.1.2.3. Surgical Service-Line Contracting
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Standardization Contracts
9.1.3.2. Sole-Source and Dual-Source Agreements
9.1.3.3. Portfolio Bundling and Capital-Consumable Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional GPO Contracts
9.1.4.3. Committed-Volume and Tiered-Pricing Agreements
9.1.5. Distributor and Specialty Surgical Supplier Sales
9.1.5.1. National Medical-Surgical Distributors
9.1.5.2. Regional Surgical Instrument Distributors
9.1.5.3. Specialty Instrument and Repair Suppliers
9.1.6. Ambulatory, Physician-Led and Public-Sector Procurement
9.1.6.1. Ambulatory Surgery Center Direct Purchasing
9.1.6.2. Physician Preference and Procedure-Specific Procurement
9.1.6.3. Federal and Veterans Health Procurement
9.1.6.4. Military and Public Hospital Tendering

What this section provides: This section explains how general surgical instruments are purchased in the U.S., including hospital contracting, IDN standardization, GPO influence, distributor channels and outpatient procurement behavior.

10. U.S. General Surgical Instruments Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Surgical Procedure Volume and Hospital Infrastructure Analysis
10.1.4. Regional Ambulatory Surgery Center Density Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.1.6. Regional Reusable Versus Disposable Adoption Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Distributors and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Distributors and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Distributors and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Distributors and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify surgical procedure hubs, hospital and ASC demand centers, technology-adoption hotspots and priority state-level commercial opportunities.

11. U.S. General Surgical Instruments Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Product Portfolio Breadth
11.2.2. Surgical Specialty Coverage
11.2.3. Hospital and IDN Contracting Strength
11.2.4. Ambulatory Surgery Center Penetration
11.2.5. Clinical Evidence and Surgeon Training Capabilities
11.2.6. Manufacturing and Supply-Chain Resilience
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Specialized and Emerging Players
11.4. Company Profiles
11.4.1. Johnson & Johnson MedTech – Ethicon
11.4.2. Medtronic
11.4.3. Stryker
11.4.4. B. Braun Medical – Aesculap
11.4.5. BD
11.4.6. Olympus Corporation of the Americas
11.4.7. CONMED Corporation
11.4.8. Integra LifeSciences
11.4.9. Teleflex Incorporated
11.4.10. Applied Medical Resources
11.4.11. KARL STORZ
11.4.12. Richard Wolf
11.4.13. Intuitive Surgical
11.4.14. CooperSurgical
11.4.15. Smith+Nephew
11.4.16. Cardinal Health
11.4.17. Medline Industries
11.4.18. STERIS
11.4.19. Aspen Surgical
11.4.20. Sklar Surgical Instruments
11.4.21. KLS Martin
11.4.22. Scanlan International
11.4.23. Microline Surgical
11.4.24. Cook Medical
11.4.25. Wexler Surgical

Company profile coverage: Each company profile will include company overview, general surgical instrument portfolio, product and technology positioning, U.S. market strategy, financial and operational positioning, distribution capabilities, clinical pipeline, regulatory updates, partnerships, acquisitions and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, product positioning, innovation direction, contracting capabilities and strategic intelligence on leading general surgical instrument companies.

12. U.S. General Surgical Instruments Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Growth Scenario
12.1.2. Realistic Growth Scenario
12.1.3. Pessimistic Growth Scenario
12.2. Disruptive Technology Impact
12.2.1. Intelligent Advanced-Energy and Tissue-Sensing Instruments
12.2.2. Powered and Smart Surgical Stapling Platforms
12.2.3. Robotic-Compatible Instruments, Articulation and Haptic Feedback
12.2.4. AI-Enabled Instrument Tracking and Surgical Workflow Analytics
12.2.5. Single-Use, Reposable and Sustainable Instrument Platforms
12.2.6. Advanced Materials and Surface Coatings
12.3. Emerging Business and Procurement Trends
12.4. Future of Reusable Versus Disposable Instrument Economics
12.5. Business Opportunities for Startups and Existing Players
12.6. Investment Prioritization Matrix
12.7. Product and Application White-Space Analysis
12.8. Regional Expansion Opportunity Matrix

What this section provides: This section prepares clients for future technology shifts, procurement model changes, investment opportunities, competitive disruption and possible market adoption scenarios through 2035.

13. U.S. General Surgical Instruments Market: Strategic Recommendations

13.1. Recommendations for General Surgical Instrument Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for Instrument Repair and Lifecycle Service Providers
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Hospital Value Analysis and Economic Evidence Strategy
13.11. Regional and State-Level Commercial Prioritization
13.12. Merger, Acquisition and Partnership Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for growth planning, product positioning, channel expansion, procurement engagement, investment decisions and competitive differentiation.

14. U.S. General Surgical Instruments Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Estimation Limitation
14.4. Forecasting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Company and Product Information Disclaimer
14.8. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, market-estimation methodology and forecasting assumptions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. General Surgical Instruments Market: Market Definition and Scope
TABLE 3: U.S. General Surgical Instruments Market: Research Methodology Framework
TABLE 4: U.S. General Surgical Instruments Market: Key Assumptions
TABLE 5: U.S. General Surgical Instruments Market: Market Ecosystem Overview
TABLE 6: U.S. General Surgical Instruments Market: Stakeholder Analysis
TABLE 7: U.S. General Surgical Instruments Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. General Surgical Instruments Market: Analyst Viewpoint Summary
TABLE 9: U.S. General Surgical Instruments Market: Market Attractiveness Index
TABLE 10: U.S. General Surgical Instruments Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. General Surgical Instruments Market: Base Year Market Positioning, 2025
TABLE 12: U.S. General Surgical Instruments Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. General Surgical Instruments Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. General Surgical Instruments Market: High-Growth Opportunity Areas
TABLE 15: U.S. General Surgical Instruments Market: Drivers; Impact Analysis
TABLE 16: U.S. General Surgical Instruments Market: Restraints; Impact Analysis
TABLE 17: U.S. General Surgical Instruments Market: Opportunities; Impact Analysis
TABLE 18: U.S. General Surgical Instruments Market: Challenges; Impact Analysis
TABLE 19: U.S. General Surgical Instruments Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. General Surgical Instruments Market: Surgical Workflow Economics Matrix
TABLE 21: U.S. General Surgical Instruments Market: Hospital Capital and Consumable Procurement Behavior Matrix
TABLE 22: U.S. General Surgical Instruments Market: Reusable Versus Disposable Lifecycle Cost Analysis
TABLE 23: U.S. General Surgical Instruments Market: Sterile-Processing Department Impact Analysis
TABLE 24: U.S. General Surgical Instruments Market: PESTEL Analysis
TABLE 25: U.S. General Surgical Instruments Market: Porter’s Five Forces Analysis
TABLE 26: U.S. General Surgical Instruments Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. General Surgical Instruments Market: Value Chain Analysis
TABLE 28: U.S. General Surgical Instruments Market: Supply Chain Analysis
TABLE 29: U.S. General Surgical Instruments Market: Stainless Steel, Titanium, Polymer and Specialty Material Analysis
TABLE 30: U.S. General Surgical Instruments Market: Digital Instrument Tracking and Operating-Room Connectivity
TABLE 31: U.S. General Surgical Instruments Market: Application & Innovation Landscape
TABLE 32: U.S. General Surgical Instruments Market: FDA Medical Device Regulatory Framework Analysis
TABLE 33: U.S. General Surgical Instruments Market: FDA Quality Management System Regulation Impact
TABLE 34: U.S. General Surgical Instruments Market: CMS Reimbursement and Procedure Payment Landscape
TABLE 35: U.S. General Surgical Instruments Market: Unique Device Identification and Traceability Requirements
TABLE 36: U.S. General Surgical Instruments Market: Import, Export and Tariff Impact
TABLE 37: U.S. General Surgical Instruments Market: Government Procurement and Public Health System Demand
TABLE 38: U.S. General Surgical Instruments Market: Impact of Escalating Geopolitical and Trade Tensions
TABLE 39: U.S. General Surgical Instruments Market: Sustainability and Medical Waste Management Analysis
TABLE 40: U.S. General Surgical Instruments Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. General Surgical Instruments Market: Product Category Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Category
TABLE 43: U.S. General Surgical Instruments Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 44: U.S. General Surgical Instruments Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 45: U.S. General Surgical Instruments Market: Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. General Surgical Instruments Market: Laparoscopic Access and Tissue-Manipulation Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. General Surgical Instruments Market: Electrosurgical and Advanced-Energy Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. General Surgical Instruments Market: Surgical Stapling and Mechanical Closure Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. General Surgical Instruments Market: Powered and Robotic-Compatible Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. General Surgical Instruments Market: Application Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Application
TABLE 52: U.S. General Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 53: U.S. General Surgical Instruments Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 54: U.S. General Surgical Instruments Market: Abdominal and Gastrointestinal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. General Surgical Instruments Market: Hernia Repair Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. General Surgical Instruments Market: Colorectal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. General Surgical Instruments Market: Bariatric and Metabolic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. General Surgical Instruments Market: Breast, Endocrine, Soft-Tissue and Trauma Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. General Surgical Instruments Market: End User Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by End User
TABLE 61: U.S. General Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 62: U.S. General Surgical Instruments Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 63: U.S. General Surgical Instruments Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. General Surgical Instruments Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. General Surgical Instruments Market: Academic Medical Centers and Teaching Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. General Surgical Instruments Market: Specialty Surgical Hospitals and Physician-Led Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. General Surgical Instruments Market: Federal, Military, Veterans Health and Safety-Net Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. General Surgical Instruments Market: Technology Type Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 70: U.S. General Surgical Instruments Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 71: U.S. General Surgical Instruments Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 72: U.S. General Surgical Instruments Market: Conventional Reusable Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. General Surgical Instruments Market: Single-Use and Disposable Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. General Surgical Instruments Market: Reposable and Hybrid Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. General Surgical Instruments Market: Energy-Enabled and Powered Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. General Surgical Instruments Market: Robotic, Sensor-Enabled and Digitally Tracked Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. General Surgical Instruments Market: Procurement Channel Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 79: U.S. General Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 80: U.S. General Surgical Instruments Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 81: U.S. General Surgical Instruments Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. General Surgical Instruments Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. General Surgical Instruments Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. General Surgical Instruments Market: Distributor and Specialty Surgical Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. General Surgical Instruments Market: Ambulatory, Physician-Led and Public-Sector Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. General Surgical Instruments Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Geography
TABLE 88: U.S. General Surgical Instruments Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. General Surgical Instruments Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: U.S. General Surgical Instruments Market: Regional Surgical Procedure Volume and Hospital Infrastructure Analysis
TABLE 91: U.S. General Surgical Instruments Market: Regional Ambulatory Surgery Center Density Analysis
TABLE 92: U.S. General Surgical Instruments Market: Regional Reimbursement and Procurement Dynamics
TABLE 93: U.S. General Surgical Instruments Market: Regional Reusable Versus Disposable Adoption Analysis
TABLE 94: West Region U.S. General Surgical Instruments Market: Regional Overview and Trends
TABLE 95: West Region U.S. General Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 96: West Region U.S. General Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. General Surgical Instruments Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. General Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. General Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. General Surgical Instruments Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. General Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 102: California General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Washington General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Arizona General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Colorado General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Oregon General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Utah General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Nevada General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: New Mexico General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Idaho General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Montana General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Wyoming General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Alaska General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Hawaii General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. General Surgical Instruments Market: Regional Overview and Trends
TABLE 116: Northeast Region U.S. General Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 117: Northeast Region U.S. General Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. General Surgical Instruments Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. General Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region U.S. General Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. General Surgical Instruments Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. General Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: New York General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Massachusetts General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: New Jersey General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Pennsylvania General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Connecticut General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Maine General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Vermont General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: New Hampshire General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Rhode Island General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Delaware General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. General Surgical Instruments Market: Regional Overview and Trends
TABLE 134: South Region U.S. General Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 135: South Region U.S. General Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. General Surgical Instruments Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. General Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. General Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: South Region U.S. General Surgical Instruments Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. General Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 141: Texas General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Florida General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Georgia General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: North Carolina General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Tennessee General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: South Carolina General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Alabama General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Mississippi General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Louisiana General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Arkansas General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Kentucky General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Oklahoma General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Virginia General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Maryland General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: West Virginia General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. General Surgical Instruments Market: Regional Overview and Trends
TABLE 157: Midwest Region U.S. General Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 158: Midwest Region U.S. General Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. General Surgical Instruments Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. General Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region U.S. General Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region U.S. General Surgical Instruments Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. General Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 164: Illinois General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Ohio General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Michigan General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Minnesota General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Indiana General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Wisconsin General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Missouri General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Iowa General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Kansas General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: Nebraska General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: North Dakota General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: South Dakota General Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 176: U.S. General Surgical Instruments Market: Competitive Landscape Snapshot, 2025
TABLE 177: U.S. General Surgical Instruments Market: Key Company Market Share Analysis, 2025
TABLE 178: U.S. General Surgical Instruments Market: Competitive Benchmarking Matrix
TABLE 179: U.S. General Surgical Instruments Market: Company Positioning Matrix
TABLE 180: U.S. General Surgical Instruments Market: Product Portfolio Benchmarking of Key Players
TABLE 181: U.S. General Surgical Instruments Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 182: Johnson & Johnson MedTech – Ethicon: Company Profile
TABLE 183: Medtronic: Company Profile
TABLE 184: Stryker: Company Profile
TABLE 185: B. Braun Medical – Aesculap: Company Profile
TABLE 186: BD: Company Profile
TABLE 187: Olympus Corporation of the Americas: Company Profile
TABLE 188: CONMED Corporation: Company Profile
TABLE 189: Integra LifeSciences: Company Profile
TABLE 190: Teleflex Incorporated: Company Profile
TABLE 191: Applied Medical Resources: Company Profile
TABLE 192: KARL STORZ: Company Profile
TABLE 193: Richard Wolf: Company Profile
TABLE 194: Intuitive Surgical: Company Profile
TABLE 195: CooperSurgical: Company Profile
TABLE 196: Smith+Nephew: Company Profile
TABLE 197: Cardinal Health: Company Profile
TABLE 198: Medline Industries: Company Profile
TABLE 199: STERIS: Company Profile
TABLE 200: Aspen Surgical: Company Profile
TABLE 201: Sklar Surgical Instruments: Company Profile
TABLE 202: KLS Martin: Company Profile
TABLE 203: Scanlan International: Company Profile
TABLE 204: Microline Surgical: Company Profile
TABLE 205: Cook Medical: Company Profile
TABLE 206: Wexler Surgical: Company Profile
TABLE 207: U.S. General Surgical Instruments Market: Future Market Scenario Analysis, 2026–2035
TABLE 208: U.S. General Surgical Instruments Market: Disruptive Technologies Impact Matrix
TABLE 209: U.S. General Surgical Instruments Market: Intelligent Advanced-Energy and Tissue-Sensing Instruments Opportunity
TABLE 210: U.S. General Surgical Instruments Market: Powered and Smart Surgical Stapling Adoption Roadmap
TABLE 211: U.S. General Surgical Instruments Market: Robotic-Compatible Instruments Opportunity Analysis
TABLE 212: U.S. General Surgical Instruments Market: AI-Enabled Instrument Tracking and Workflow Analytics Impact
TABLE 213: U.S. General Surgical Instruments Market: Single-Use, Reposable and Sustainable Instrument Platforms
TABLE 214: U.S. General Surgical Instruments Market: Advanced Materials and Surface Coatings Opportunity
TABLE 215: U.S. General Surgical Instruments Market: Emerging Business and Procurement Trends
TABLE 216: U.S. General Surgical Instruments Market: Future Reusable Versus Disposable Instrument Economics
TABLE 217: U.S. General Surgical Instruments Market: Business Opportunities for Startups and Existing Players
TABLE 218: U.S. General Surgical Instruments Market: Investment Prioritization Matrix
TABLE 219: U.S. General Surgical Instruments Market: Product and Application White-Space Analysis
TABLE 220: U.S. General Surgical Instruments Market: Regional Expansion Opportunity Matrix
TABLE 221: U.S. General Surgical Instruments Market: Strategic Recommendations for Instrument Manufacturers
TABLE 222: U.S. General Surgical Instruments Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 223: U.S. General Surgical Instruments Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 224: U.S. General Surgical Instruments Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 225: U.S. General Surgical Instruments Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 226: U.S. General Surgical Instruments Market: Strategic Recommendations for Instrument Repair and Lifecycle Service Providers
TABLE 227: U.S. General Surgical Instruments Market: Strategic Recommendations for New Entrants and Startups
TABLE 228: U.S. General Surgical Instruments Market: Go-to-Market Strategy Considerations
TABLE 229: U.S. General Surgical Instruments Market: Product Positioning and Portfolio Expansion Guidance
TABLE 230: U.S. General Surgical Instruments Market: Hospital Value Analysis and Economic Evidence Strategy
TABLE 231: U.S. General Surgical Instruments Market: Regional and State-Level Commercial Prioritization
TABLE 232: U.S. General Surgical Instruments Market: Merger, Acquisition and Partnership Opportunity Assessment
TABLE 233: U.S. General Surgical Instruments Market: Scope Limitation
TABLE 234: U.S. General Surgical Instruments Market: Data Use Limitation
TABLE 235: U.S. General Surgical Instruments Market: Market Estimation Limitation
TABLE 236: U.S. General Surgical Instruments Market: Forecasting Limitation
TABLE 237: U.S. General Surgical Instruments Market: Legal Disclaimer
TABLE 238: U.S. General Surgical Instruments Market: Third-Party Data Disclaimer
TABLE 239: U.S. General Surgical Instruments Market: Company and Product Information Disclaimer
TABLE 240: U.S. General Surgical Instruments Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. General Surgical Instruments Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Data Triangulation and Forecasting Framework
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. General Surgical Instruments Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. General Surgical Instruments Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. General Surgical Instruments Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. General Surgical Instruments Market Dynamics
FIGURE 10: Drivers Impact Analysis
FIGURE 11: Restraints Impact Analysis
FIGURE 12: Opportunities Impact Analysis
FIGURE 13: Challenges Impact Analysis
FIGURE 14: Innovation & Patent Landscape, 2021–2025
FIGURE 15: Surgical Workflow Economics Framework
FIGURE 16: Hospital Capital and Consumable Procurement Decision Framework
FIGURE 17: Reusable Versus Disposable Lifecycle Cost Framework
FIGURE 18: Sterile-Processing Department Impact Framework
FIGURE 19: PESTEL Analysis
FIGURE 20: Porter’s Five Forces Analysis
FIGURE 21: Value Chain Analysis
FIGURE 22: Supply Chain Analysis
FIGURE 23: Surgical Instrument Materials Landscape
FIGURE 24: Digital Instrument Tracking and Operating-Room Connectivity Framework
FIGURE 25: FDA Regulatory and Quality Management Framework
FIGURE 26: CMS Reimbursement and Procedure Payment Landscape
FIGURE 27: Sustainability and Medical Waste Management Framework
FIGURE 28: Hospital Value Analysis Committee Decision Framework
FIGURE 29: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Handheld Surgical Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Laparoscopic Access and Tissue-Manipulation Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Electrosurgical and Advanced-Energy Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Surgical Stapling and Mechanical Closure Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Powered and Robotic-Compatible Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Abdominal and Gastrointestinal Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hernia Repair Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Colorectal Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Bariatric and Metabolic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Breast, Endocrine, Soft-Tissue and Trauma Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 44: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Academic Medical Centers and Teaching Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Specialty Surgical Hospitals and Physician-Led Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Federal, Military, Veterans Health and Safety-Net Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Conventional Reusable Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Single-Use and Disposable Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Reposable and Hybrid Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Energy-Enabled and Powered Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Robotic, Sensor-Enabled and Digitally Tracked Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 58: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Distributor and Specialty Surgical Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Ambulatory, Physician-Led and Public-Sector Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 65: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Regional Surgical Procedure Volume and Hospital Infrastructure Heat Map
FIGURE 67: Regional Ambulatory Surgery Center Density Map
FIGURE 68: Regional Reimbursement and Procurement Dynamics Map
FIGURE 69: West Region U.S. General Surgical Instruments Market Share and Leading Players, 2025
FIGURE 70: West Region Market Share Analysis by State, 2025
FIGURE 71: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: California General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Washington General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Arizona General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Colorado General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Oregon General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Utah General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Nevada General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Mexico General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Idaho General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Montana General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Wyoming General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Alaska General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Hawaii General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Northeast Region U.S. General Surgical Instruments Market Share and Leading Players, 2025
FIGURE 86: Northeast Region Market Share Analysis by State, 2025
FIGURE 87: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: New York General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Massachusetts General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: New Jersey General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Pennsylvania General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Connecticut General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Maine General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Vermont General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: New Hampshire General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Rhode Island General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Delaware General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: South Region U.S. General Surgical Instruments Market Share and Leading Players, 2025
FIGURE 99: South Region Market Share Analysis by State, 2025
FIGURE 100: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Texas General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Florida General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Georgia General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: North Carolina General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Tennessee General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: South Carolina General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Alabama General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Mississippi General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Louisiana General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Arkansas General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Kentucky General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Oklahoma General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Virginia General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Maryland General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: West Virginia General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Midwest Region U.S. General Surgical Instruments Market Share and Leading Players, 2025
FIGURE 117: Midwest Region Market Share Analysis by State, 2025
FIGURE 118: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Illinois General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Ohio General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Michigan General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Minnesota General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Indiana General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Wisconsin General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 125: Missouri General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 126: Iowa General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 127: Kansas General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 128: Nebraska General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 129: North Dakota General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 130: South Dakota General Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 131: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 132: Company Positioning Matrix
FIGURE 133: Key Player Product Portfolio Benchmarking
FIGURE 134: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 135: General Surgical Instruments Innovation Roadmap
FIGURE 136: Future Market Scenario Analysis, 2026–2035
FIGURE 137: Disruptive Technologies Impact Matrix
FIGURE 138: Intelligent Advanced-Energy and Tissue-Sensing Instruments Adoption Roadmap
FIGURE 139: Powered and Smart Surgical Stapling Opportunity Map
FIGURE 140: Robotic-Compatible Instruments Growth Roadmap
FIGURE 141: AI-Enabled Instrument Tracking and Workflow Analytics Roadmap
FIGURE 142: Single-Use, Reposable and Sustainable Instrument Platform Opportunity Map
FIGURE 143: Advanced Materials and Surface Coatings Innovation Roadmap
FIGURE 144: Emerging Business and Procurement Trends Matrix
FIGURE 145: Future Reusable Versus Disposable Instrument Economics
FIGURE 146: Investment Prioritization Matrix
FIGURE 147: Product and Application White-Space Opportunity Map
FIGURE 148: Regional Expansion Opportunity Matrix
FIGURE 149: Strategic Growth Roadmap for U.S. General Surgical Instrument Companies
FIGURE 150: Go-to-Market Strategy Framework
FIGURE 151: Product Positioning and Portfolio Expansion Framework
FIGURE 152: Hospital Value Analysis and Economic Evidence Framework
FIGURE 153: Merger, Acquisition and Partnership Opportunity Framework
FIGURE 154: Report Scope and Disclaimer Framework